Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-14-016961
Filing Date
2014-03-21
Accepted
2014-03-20 20:49:03
Documents
1
Group Members
MERIDIAN VENTURE PARTNERS II, CO.MERIDIAN VENTURE PARTNERS II, L.P.ROBERT E. BROWN, JR.THOMAS A. PENN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D v372264_sc13da.htm SC 13D/A 151099
  Complete submission text file 0001144204-14-016961.txt   152974
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60689 | Film No.: 14708071
SIC: 2834 Pharmaceutical Preparations

Mailing Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087
Business Address 259 N. RADNOR-CHESTER ROAD SUITE 130 RADNOR PA 19087 610-254-2999
Meridian Venture Partners II GP, L.P. (Filed by) CIK: 0001580170 (see all company filings)

EIN.: 233030799 | State of Incorp.: DE | Fiscal Year End: 1213
Type: SC 13D/A